Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Halozyme Therapeutics, Inc. Q3 2009 Earnings Call Transcript
- Question-and-Answer SessionOperator Operator Instructions. And your first question comes from the line of Eun Yang. Eun Yang – Jefferies & Company Thanks. Regarding the Baxter collaboration for subcu GAMMAGARD, CSL also has subcutaneous immunoglobulin product that is currently under regulatory review. Could you Jonathan – could you comment on...
- Earnings calls 2009-11-06
- << Previous
- page 1 of 1
- Next >>